← Back to Search

Cancer Patient Empowerment Program for Cancer (CancerPEP Trial)

N/A
Waitlist Available
Research Sponsored by Nova Scotia Health Authority
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 6 - 24 months
Awards & highlights

CancerPEP Trial Summary

This trial found that the C-PEP program significantly improved quality of life and mental and physical health in cancer patients and survivors.

Who is the study for?
This trial is for cancer patients and survivors over 18 who can access daily emails, watch YouTube videos, understand English, and are safe to exercise. They should expect to live more than a year and be able to complete surveys throughout the program. Approval from physicians may be required for those with certain health conditions.Check my eligibility
What is being tested?
The Cancer Patient Empowerment Program (CancerPEP) is being tested. It's a six-month online program that includes strength training, yoga, stress reduction techniques, dietary advice through daily emails aimed at improving life quality and health in cancer patients.See study design
What are the potential side effects?
Since this intervention involves lifestyle changes rather than medication or medical procedures, side effects might include muscle soreness or strain from new exercises. Stress reduction activities are generally considered safe but always consult with healthcare providers.

CancerPEP Trial Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~6 - 24 months
This trial's timeline: 3 weeks for screening, Varies for treatment, and 6 - 24 months for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Feasibility (accrual, attrition, compliance, and adverse events)
Secondary outcome measures
Alcohol Habit assessed by questions from the NIH Alcohol Consumption questionnaire.
Anxiety
Availability of social support assessed by the MOS Social Support Survey
+15 more

CancerPEP Trial Design

2Treatment groups
Experimental Treatment
Group I: Intervention without HRV monitorExperimental Treatment1 Intervention
Group II: Intervention with HRV monitorExperimental Treatment1 Intervention

Find a Location

Who is running the clinical trial?

Dalhousie UniversityOTHER
167 Previous Clinical Trials
403,034 Total Patients Enrolled
Nova Scotia Health AuthorityLead Sponsor
257 Previous Clinical Trials
83,710 Total Patients Enrolled

Media Library

CancerPEP Clinical Trial Eligibility Overview. Trial Name: NCT05508412 — N/A
Cancer Research Study Groups: Intervention with HRV monitor, Intervention without HRV monitor
Cancer Clinical Trial 2023: CancerPEP Highlights & Side Effects. Trial Name: NCT05508412 — N/A
CancerPEP 2023 Treatment Timeline for Medical Study. Trial Name: NCT05508412 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Are they still accepting participants into this research endeavor?

"According to the information on clinicaltrials.gov, this particular trial is no longer recruiting participants. It was initially published on November 15th 2022 and underwent its last edit in August of 2022. Nonetheless, 485 other studies are presently seeking patients for their respective trials."

Answered by AI

Who else is applying?

What state do they live in?
California
What portion of applicants met pre-screening criteria?
Did not meet criteria
How many prior treatments have patients received?
2
~37 spots leftby Feb 2025